SCHEMBL382192

SCHEMBL382192

NC(CNC(=O)O)c1cccc(C(F)(F)F)c1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PNMT P11086 1/20 0.50
TACR1 P25103 3/20 0.47
ACP3 P15309 2/20 0.47
CES2 O00748 1/20 0.47
BCHE P06276 2/20 0.46
EPHX1 P07099 1/20 0.45
MEN1 O00255 1/20 0.45
ALDH1A1 P00352 1/20 0.45
CYP1A2 P05177 1/20 0.45
POLB P06746 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C9 P11712 1/20 0.45
KMT2A Q03164 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
SLC6A9 P48067 1/20 0.45
IDO1 P14902 1/20 0.44
TDO2 P48775 1/20 0.44
GPR139 Q6DWJ6 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL381834 0.99 PNMT (0.49) PNMTTACR1ACP3CES2BCHE
SCHEMBL10216749 0.87 PNMT (0.49) PNMTTACR1ACP3CES2BCHE
SCHEMBL20764645 0.86 TACR1 (0.49) PNMTTACR1ACP3CES2BCHE
SCHEMBL20764642 0.86 TACR1 (0.49) PNMTTACR1ACP3CES2BCHE
SCHEMBL30412649 0.86 TACR1 (0.49) PNMTTACR1ACP3CES2BCHE
Hydrochloric Acid SCHEMBL381985 0.86 PNMT (0.48) PNMTTACR1ACP3CES2BCHE
SCHEMBL20764675 0.86 PNMT (0.48) PNMTTACR1ACP3CES2BCHE
SCHEMBL380780 0.86 PNMT (0.48) PNMTTACR1ACP3CES2BCHE
SCHEMBL20764665 0.85 PNMT (0.47) PNMTTACR1CES2BCHEEPHX1
SCHEMBL30411420 0.85 PNMT (0.47) PNMTTACR1CES2BCHEEPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2408751-B1 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof BAYER IP GMBH (DE) 2017-08-23 EP disclosed
EP-2408751-A1 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof Bayer Pharma Aktiengesellschaft (DE) 2012-01-25 EP disclosed
WO-2010105770-A1 SUBSTITUTED 2-ACETAMIDO-5-ARYL-1,2,4-TRIAZOLONES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-09-23 WO disclosed
EP-1968568-A2 INHIBITORS OF Akt ACTIVITY SmithKline Beecham Corporation (US) 2008-09-17 EP disclosed
WO-2007076423-A2 INHIBITORS OF Akt ACTIVITY SMITHKLINE BEECHAM CORPORATION (US) 2007-07-05 WO disclosed